InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Tyagi Ashu. Director active across 1 company, notably Y-mAbs Therapeutics, Inc.. In total, 4 filings have been published. Activity tracked since 8 June 2023. The latest transaction was filed on 16 September 2025 (U). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations